Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats

American Journal of Hypertension

Volumn 9, Issue 9, 1996, Pages 867-877

  Singh, Ava ^a   Sventek, Pavol ^a   Larivière, Richard ^a   Thibault, Gaétan ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Blood vessels; Endothelium; Endothelium derived relaxing factor; Hypertension; Interleukin 1 ; Nitric oxide synthase; Spontaneously hypertensive rat; Vascular smooth muscle

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0030250314     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00104-5     Document Type: Article

References (53)

1. 1. Moncada S, Palmer R, Higgs E: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
2. 2. Knowles R, Palacios M, Palmer R, Moncada S: Formation of nitric oxide from L-arginine in the central nervous system. A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 1989;86:5159-5162.
3. 3. Lamas S, Marsden P, Li G, et al: Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992;89:6348-6352.
4. 4. Marietta M, Yoon P, Iyengar R, et al: Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988;27:8706-8711.
5. 5. Kilbourn R, Belloni I: Endothelial cell production of nitrogen oxides in response to interferon in combination with tumor necrosis factor. J Natl Cancer Inst 1990; 82:772-776.
6. 6. Busse R, Mülsch A: Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990;275:87-90.
7. 7. Iida S, Ohshima H, Oguchi, et al: Identification of inducible calmodulin dependent nitric oxide synthase in the liver of rats. J Biol Chem 1992;267:25385-25388.
8. 8. Jorens P, Van OF, Vermeire P, et al: Synergism between interleukin-1 beta and interferon gamma, an inducer of nitric oxide synthase in rat lung fibroblasts. Eur J Pharmacol 1992;224:7-12.
9. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105:575-580.
10. 10. Balligand J, Ungureanu-Longrois D, Simmons W, et al: Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 1994; 269:27580-27588.
11. 11. Deng LY, Thibault G, Schiffrin EL: Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens [A] 1993;15:527-537.
12. 12. Rees DD, Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc NaU Acad Sci USA 1989;86:3375-3378.
13. 13. Lockette W, Otsuka Y, Carretero O: The loss of endothelium-dependent relaxation in hypertension. Hypertension 1986;8(suppl II):II-61-II-66.
14. G-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol 1991;102:823-826.
15. 15. Beasley D, Schwartz JH, Brenner BM: Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin Invest 1991;87:602-608.
16. 16. Schini VB, Junquero DC, Scott-Burden T, Vanhoutte PM: Interleukin-1 induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun 1991;176:114-121.
17. 17. Durante W, Schini VB, Scott-Burden T, et al: Platelet inhibition by an L-arginine-derived substance released by interleukin-1-treated cultured vascular smooth muscle cells. Am J Physiol 1991;261:H2024-H2030.
18. 18. Kanno K, Hirata Y, Imai T, Marumo F: Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 1993;22:34-39.
19. 19. Beasley D, Eldridge M: Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol 1994; 256:R1197-R1203.
20. 20. Schiffrin EL, Poissant L, Cantin M, Thibault G: Receptors for atrial natriuretic factor in cultured vascular smooth muscle cells. Life Sci 1986;38:817-826.
21. 21. Steiner AL, Parker CW, Kipnis DM: Radioimmuoassay for cyclic nucleotides. 1. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem 1972;247: 1106-1113.
22. 22. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162: 156-159.
23. 23. Nunokawa Y, Ishida N, Tanaka S: Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993;191:89-94.
24. 24. Torczynski R, Bollon AP, Fuke M: The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with the respective yeast and frog genes. Nucleic Acids Res 1983;11:4879-4890.
25. 25. Takeichi N, Suzuki K, Okayasu H, Kobayashi H: Immunological depression in spontaneously hypertensive rats. Clin Exp Immunol 1980;40:120-126.
26. 26. Khraibi AA, Norman RA, Dzielak DJ: Chronic immunosuppression attentuates hypertension in Okamoto spontaneously hypertensive rats. Am J Physiol 1984; 247:H722-H726.
27. 27. Fannon LD, Braylan RC, Phillips MI: Alterations of lymphocyte populations during development in the spontaneously hypertensive rat. J Hypertens 1992; 10:629-634.
28. 28. Dzielak DJ: Immune mechanisms in experimental and essential hypertension. Am J Physiol 1991;260:R459-R467.
29. 29. Schmid-Schönbein GW, Seiffge D, DeLano FA, et al: Leucocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 1991; 17:323-330.
30. 30. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.
31. 31. Katz SD, Rao R, Berman JW, et al: Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 1994; 90:12-16.
32. 32. O'Murchu B, Miller VM, Perrella MA, Burnett JC: Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest 1994; 93:165-171.
33. 33. Owens GK, Schwartz SM: Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 1982;51:280-289.
34. 34. Resink TJ, Scott-Burden T, Jones CR, et al: Increased proliferation rate and phosphoinostide turnover in cultured smooth muscle cells from spontaneously hypertensive rats. J Hypertens 1987;5(suppl 5):S145-S148.
35. 35. Hadrava V, Tremblay J, Hamet P: Abnormalities in growth characteristics of aorta smooth muscle cells in spontaneously hypertensive rats. Hypertens 1989; 13:589-597.
36. 36. Scott-Burden T, Resink TJ, Baur U, et al: Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension 1989;13:295-304.
37. 37. Berk BC, Vallega G, Muslin AJ, et al: Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na/H exchange. J Clin Invest 1989;83:822-829.
38. 38. Nussler AK, Liu ZZ, DiSilvo M, et al: Hepatocyte inducible nitric oxide synthesis is influenced in vitro by cell density. Am J Physiol 1994;266(Cell Physiol 35):C394-C401.
39. 39. Malinski T, Kapturczak M, Dayharsh J, Bohr D: Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 1993;194:654-658.
40. 40. Junquero DC, Scott-Burden T, Schini VB, Vanhoutte PM: The production of nitric oxide by interleukin-1 in cultured aortic smooth muscle cells from spontaneously hypertensive rats is greater than that from normotensive rats, in Sassard J (ed): Genetic Hypertension. Colloque INSERM/John Libbey Eurotex Ltd., Paris, 1992;218:3-5.
41. 41. Xiao J, Pang PKT: Does a general alteration in nitric oxide synthesis system occur in spontaneously hypertensive rats? Am J Physiol 1994;266:H272-H278.
42. 42. Salvemini D, Misko TP, Masferrer JL, et al: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-7244.
43. 43. Stamler JS, Simon DI, Osborne JA, et al: S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992;89:444-448.
44. 44. Bolotina VM, Najibi SN, Palacino JJ, et al: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368:850-853.
45. 45. Wink DA, Osawa Y, Darby shire JF, et al: Inhibition of cytochrome P-450 by nitric oxide and a nitric oxide releasing agent. Arch Biochem Biophys 1993;300:115-123.
46. 46. Rengasamy A, Johns RA: Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 1993;44:124-128.
47. 47. Assreuy J, Cunha Q, Liew FY, Moncada S: Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 1993;108:833-837.
48. 48. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ: Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993;73:808-812.
49. 49. Perrella M, Yoshizumi M, Fen Z, et al: Transforming growth factor-β but not dexamethasone down-regulates nitric oxide synthase mRNA after its induction by IL-1β in rat smooth muscle cells. J Biol Chem 1994; 269:14595-14600.
50. 50. Koide M, Kawahara Y, Tsuda T, et al: Expression of nitric oxide synthase by cytokines in vascular smooth muscle cells. Hypertension 1994;23(suppl 1):I-45-I-48.
51. 51. Geller DA, Nussler AK, Di Silvio M, et al: Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad USA 1993;90:522-526.
52. 52. Lee L, Webb RC: Endothelium-dependent relaxation and L-arginine metabolism in genetic hypertension. Hypertension 1992;19:435-441.
53. G-nitro arginine produces an exaggerated hypertension in anaesthetized SHR. Eur J Pharmacol 1991;197:239-240.